Fizazi, Ariane, Chris Serrand, Alexandre Evrard, Blanche Bergeret, Pierre-Emmanuel Stoebner, and Myriam Marque. 2024. “High BRAF V600 Mutation Level Associated With Worse Outcome in Metastatic Melanoma Patients Receiving BRAF and MEK Inhibitors”. Acta Dermato-Venereologica 104 (November):adv40913. https://doi.org/10.2340/actadv.v104.40913.